Everolimus Viatris 5 mg tablete
| Name | Everolimus Viatris 5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-352247791 |
| Active Substance | everolimus |
| Composition | jedna tableta sadrži 5 mg everolimusa |
| Pharmaceutical Form | tableta |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska Synthon BV, Nijmegen, Nizozemska |
| Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 21.10.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/135 |
| Registration Number | 381-12-01/70-24-11 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EG02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
